What can the food industry teach pharma about the benefits of digital supply chain compliance monitoring and management?

8

Given the criticality of end-to-end quality assurance to pharma compliance, marketing authorisation and patient safety, it is puzzling that entire industry supply chains are not subjected to more rigorous, systemised scrutiny. Even today, the vast majority of drug manufacturers perform global supplier vetting, logging, updating and reporting manually. This outdated approach is fraught with risk, while its labour intensity can result in annual costs approaching 100,000 euros for smaller companies and over half a million for larger entities, to monitor and manage all suppliers.